Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BELLUS Health Inc.

    NASDAQ: BLU · Real-Time Price · USD
    14.74
    0.00 (0.00%)
    At close: Jun 28, 2023, 9:59 PM

    BELLUS Health Statistics

    Share Statistics

    BELLUS Health has 126.81M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 126.81M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 92.13M

    Failed to Deliver (FTD) Shares

    n/a
    		 166,000

    FTD / Avg. Volume

    n/a
    		 3.08%

    Short Selling Information

    The latest short interest is 6.65M, so 5.24% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.65M

    Short % of Shares Out

    n/a
    		 5.24%

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 2.58

    Valuation Ratios

    The PE ratio is -12.46 and the forward PE ratio is null. BELLUS Health's PEG ratio is 0.47.

    PE Ratio

    n/a
    		 -12.46

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 59265.57

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.43

    P/FCF Ratio

    n/a
    		 -9.68

    PEG Ratio

    n/a
    		 0.47
    Financial Ratio History

    Enterprise Valuation

    BELLUS Health has an Enterprise Value (EV) of 862.28M.

    EV / Sales

    n/a
    		 53892.63

    EV / EBITDA

    n/a
    		 -11.85

    EV / EBIT

    n/a
    		 -11.18

    EV / FCF

    n/a
    		 -8.8

    Financial Position

    The company has a current ratio of 22.42, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 22.42

    Quick Ratio

    n/a
    		 22.42

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -998.5

    Financial Efficiency

    Return on Equity is -19.46% and Return on Invested Capital is -19.87%.

    Return on Equity

    n/a
    		 -19.46%

    Return on Assets

    n/a
    		 -18.66%

    Return on Invested Capital

    n/a
    		 -19.87%

    Revenue Per Employee

    n/a
    		 $216.22

    Profits Per Employee

    n/a
    		 $-1,028,108.11

    Employee Count

    n/a
    		 74

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 3.51B

    Taxes

    Income Tax

    n/a
    		 60K

    Effective Tax Rate

    n/a
    		 -0.08%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is -0.28, so BELLUS Health's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.28

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 14.55

    200-Day Moving Average

    n/a
    		 10.13

    Relative Strength Index (RSI)

    n/a
    		 78.88

    Average Volume (20 Days)

    n/a
    		 5,381,551

    Income Statement

    In the last 12 months, BELLUS Health had revenue of 16K and earned -76.08M in profits. Earnings per share was -0.66.

    Revenue

    n/a
    		 16K

    Gross Profit

    n/a
    		 -3.51B

    Operating Income

    n/a
    		 -77.88M

    Net Income

    n/a
    		 -76.08M

    EBITDA

    n/a
    		 -72.76M

    EBIT

    n/a
    		 -75.94M

    Earnings Per Share (EPS)

    n/a
    		 -0.66
    Full Income Statement

    Balance Sheet

    The company has 87.25M in cash and 1.28M in debt, giving a net cash position of 85.97M.

    Cash & Cash Equivalents

    n/a
    		 87.25M

    Total Debt

    n/a
    		 1.28M

    Net Cash

    n/a
    		 85.97M

    Retained Earnings

    n/a
    		 -641.84M

    Total Assets

    n/a
    		 3.09B

    Working Capital

    n/a
    		 890.08M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -77.1M and capital expenditures -20.89M, giving a free cash flow of -97.98M.

    Operating Cash Flow

    n/a
    		 -77.1M

    Capital Expenditures

    n/a
    		 -20.89M

    Free Cash Flow

    n/a
    		 -97.98M

    FCF Per Share

    n/a
    		 -0.85
    Full Cash Flow Statement

    Margins

    Gross margin is -21967104.08%, with operating and profit margins of -486768.75% and -475500%.

    Gross Margin

    n/a
    		 -21967104.08%

    Operating Margin

    n/a
    		 -486768.75%

    Pretax Margin

    n/a
    		 -475125%

    Profit Margin

    n/a
    		 -475500%

    EBITDA Margin

    n/a
    		 -454768.75%

    EBIT Margin

    n/a
    		 -486768.75%

    FCF Margin

    n/a
    		 -612387.7%

    Dividends & Yields

    BLU does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -8.02%

    FCF Yield

    n/a
    		 -10.33%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BLU.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 19, 2019. It was a backward split with a ratio of 5:18.

    Last Split Date

    n/a
    		 Aug 19, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 5:18

    Scores

    Altman Z-Score

    n/a
    		 1.12

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist